Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil Randomized Withdrawal in Pediatric ADHD
NCT00343811Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Modafinil with Placebo (2 arms). Primary endpoint: ADHD Rating Scale-IV Total Score at 6 weeks. Started Jun 2006; status: completed.
02
Drugs
modafinil
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00343811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343811.